Supernus Pharmaceuticals
SUPN
#4033
Rank
$2.91 B
Marketcap
$50.90
Share price
-0.89%
Change (1 day)
35.49%
Change (1 year)

Market capitalization of Supernus Pharmaceuticals (SUPN)

Market cap: $2.91 Billion USD

As of January 2026 Supernus Pharmaceuticals has a market cap of $2.91 Billion USD. This makes Supernus Pharmaceuticals the world's 4033th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Supernus Pharmaceuticals from 2012 to 2026

End of year Market Cap

Year Marketcap Change
2026$2.91 B-1.29%
2025$2.95 B44.03%
2024$2.05 B29.85%
2023$1.58 B-18%
2022$1.92 B24.34%
2021$1.55 B16.58%
2020$1.33 B6.75%
2019$1.24 B-28.3%
2018$1.73 B-14.92%
2017$2.04 B63.31%
2016$1.25 B89.92%
2015$0.65 B84.65%
2014$0.35 B18.31%
2013$0.30 B37.31%
2012$0.21 B

End of Day market cap according to different sources

On Jan 12th, 2026 the market cap of Supernus Pharmaceuticals was reported to be:

$2.94 Billion USD
by Nasdaq info icon info icon
$2.94 Billion USD
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Zogenix
ZGNX
$1.50 B-48.60%๐Ÿ‡บ๐Ÿ‡ธ USA
United Therapeutics
UTHR
$21.44 B 634.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
$966.96 B 33,028.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
$113.97 B 3,804.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
$214.91 B 7,262.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
$515.26 B 17,552.92%๐Ÿ‡บ๐Ÿ‡ธ USA